A Proteomic Analysis of the AHR signaling Network

AHR 信号网络的蛋白质组学分析

基本信息

  • 批准号:
    7599127
  • 负责人:
  • 金额:
    $ 24.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Aryl hydrocarbon receptor (AHR) agonists, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), are some of the most toxic chemicals known to man. They also hold 4 of the top 10 positions within the EPA-ATSDR registry of priority substances that contaminate National Priority List. The toxicity of these compounds is primarily dependent upon the presence of a functional AHR signaling complex. This complex, in the absence of ligand consists of the AHR bound to a dimer of the heat shock protein of 90 kDa (Hsp90), the immunophilin-like protein, ARA9 (also known as XAP2 and AIP) and possibly several other factors (eg pp60src, p21). The role these chaperones play and their mechanism of action remains largely unknown. Our recent preliminary experiments suggest that ARA9 may function by recruiting other cellular factors to the AHR cytosolic complex. The role these cellular factors and other signaling systems play in the formation and integrity of the AHR cytosolic complex (upstream events) and how these other complex proteins influence AHR mediated toxicity (downstream events) has not been thoroughly explored. These signals may play important roles in the tissue specific biology and toxicity of AHR agonists. Our preliminary data and recent literature have led us to hypothesize: Secondary signaling, both upstream and downstream, plays an important role in AHR mediated signaling and toxicity through direct influence of the activity of the AHR cytosolic complex and perturbations of downstream signaling cascades. To address the hypothesis this project will look at the effects of secondary signaling on AHR biology in four specific aims (SA). SA1) Identify and characterize the proteins capable of interacting with the AHR in liver and immune cells in the absence and presence of ligand using tandem affinity purification, mass spectrometry and retroviral mediated gene transfer. SA2) Determine the fate of AHR complex members following ligand exposure using mass spectrometry and retroviral mediated gene transfer. SA3) Characterize the role of AHR-interacting proteins in ligand-induced signaling using RNAi, transient transfections and functional assays. SA4) Create a functional interaction network map for the AHR using proteins identified in the first aims and published reports and determine its overlap with regulatory networks. The completion of these aims will create a detailed picture of the AHR protein interaction network (AHR-PIN) and directly relate the proteins in this PIN to functional consequences for AHR mediated toxicity. Finally, the computational model that will be developed will generate new mechanistic directions for understanding the toxicity of AHR ligands and allow more accurate risk assessment for Superfund sites.
芳烃受体(AHR)激动剂,如2,3,7,8-四氯二苯并-对二恶英(TCDD),是其中的一些

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN J LAPRES其他文献

JOHN J LAPRES的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN J LAPRES', 18)}}的其他基金

A Proteomic Analysis of the AHR signaling Network
AHR 信号网络的蛋白质组学分析
  • 批准号:
    7064102
  • 财政年份:
    2006
  • 资助金额:
    $ 24.87万
  • 项目类别:
Hypoxia and Epigenetic Mechanisms for Toxicity
缺氧和毒性的表观遗传机制
  • 批准号:
    7249502
  • 财政年份:
    2005
  • 资助金额:
    $ 24.87万
  • 项目类别:
Hypoxia and Epigenetic Mechanisms for Toxicity
缺氧和毒性的表观遗传机制
  • 批准号:
    7458927
  • 财政年份:
    2005
  • 资助金额:
    $ 24.87万
  • 项目类别:
Hypoxia and Epigenetic Mechanisms for Toxicity
缺氧和毒性的表观遗传机制
  • 批准号:
    6976787
  • 财政年份:
    2005
  • 资助金额:
    $ 24.87万
  • 项目类别:
Hypoxia and Epigenetic Mechanisms for Toxicity
缺氧和毒性的表观遗传机制
  • 批准号:
    7097467
  • 财政年份:
    2005
  • 资助金额:
    $ 24.87万
  • 项目类别:
Proteomics and the dioxin signaling network
蛋白质组学和二恶英信号网络
  • 批准号:
    6562377
  • 财政年份:
    2002
  • 资助金额:
    $ 24.87万
  • 项目类别:
Proteomics and the dioxin signaling network
蛋白质组学和二恶英信号网络
  • 批准号:
    6657397
  • 财政年份:
    2002
  • 资助金额:
    $ 24.87万
  • 项目类别:
FKBH37 AS A MODIFIER OF DIOXIN TOXICITY
FKBH37 作为二恶英毒性调节剂
  • 批准号:
    2770731
  • 财政年份:
    1999
  • 资助金额:
    $ 24.87万
  • 项目类别:
FKBH37 AS A MODIFIER OF DIOXIN TOXICITY
FKBH37 作为二恶英毒性调节剂
  • 批准号:
    6077936
  • 财政年份:
    1999
  • 资助金额:
    $ 24.87万
  • 项目类别:
Multidisciplinary Training in Environmental Toxicology
环境毒理学多学科培训
  • 批准号:
    9307838
  • 财政年份:
    1989
  • 资助金额:
    $ 24.87万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 24.87万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.87万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 24.87万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.87万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 24.87万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 24.87万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.87万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 24.87万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 24.87万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.87万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了